Yahoo! Finance Search - Finance Home - Yahoo! - Help

Wednesday, October 22 2014 8:43pm ET - U.S. Markets Closed.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Wednesday, Oct 22, 2014
·Abbott, Mylan silent on why changing tax-inversion terms
Reuters - 2 hours, 21 minutes ago
·Illumina Breaks Out Of Double-Bottom Base
at Investor's Business Daily, Inc. - 2 hours, 50 minutes ago
·Harvoni® (ledipasvir/sofosbuvir) approved for the treatment of chronic hepatitis C, genotype 1 infection in adults; Diplomat to distribute
PR Newswire - Wed 4:53 pm ET
·Innocoll AG Proposes Changes to Supervisory Board and Stock Option Plan
GlobeNewswire - Wed 4:30 pm ET
·Mylan-Abbott Inversion Deal Is On… With Some Changes
at The Wall Street Journal Online - Wed 12:18 pm ET
·Boehringer Ingelheim says not interested in buying Omega Pharma
Reuters - Wed 10:10 am ET
·3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion
- Wed 10:05 am ET
·Flexion Therapeutics, Inc. (Nasdaq: FLXN) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire - Wed 10:00 am ET
·REUTERS AMERICA NEWS PLAN FOR WEDNESDAY OCT 22
Reuters - Wed 9:48 am ET
·Abbott, Mylan back generics deal, tweak terms after tax rule change
Reuters - Wed 9:24 am ET
·Corium International (CORI) Jumps: Stock Adds 8.9%
Zacks.com - Wed 8:49 am ET
·Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
PR Newswire - Wed 8:30 am ET
·Abbott says third-quarter sales match forecasts
Reuters - Wed 8:11 am ET
·Momenta Pharmaceuticals Announces Date of Third Quarter 2014 Financial Results Conference Call and Webcast
GlobeNewswire - Wed 8:00 am ET
·Akorn (AKRX) Looks Good: Stock Adds 5.8% in Session
Zacks.com - Wed 7:22 am ET
·Medicines Co. beats 3Q earnings expectations
AP - Wed 7:16 am ET
·The Medicines Company Reports Third Quarter and First Nine Months 2014 Results
Business Wire - Wed 7:00 am ET
·French developer of "peanut allergy patch" makes U.S. debut
Reuters - Wed 4:06 am ET
Tuesday, Oct 21, 2014
·Horizon Pharma plc to Host Third Quarter 2014 Conference Call and Webcast on November 6, 2014
Marketwire - Tue 4:05 pm ET
·Akorn, Inc. Announces Third Quarter 2014 Earnings Release and Conference Call Information
GlobeNewswire - Tue 11:02 am ET
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
www.OmegaStatistics.com
College Degree Online
Get Degree With $5,730 University or College Grant if Qualify. Act Now.
Degree-Accredited.com/Institute
Anti-Aging Creams Review
Report: How to lose wrinkles fast for practically $0. Limited supply
antiagingworld.org/AntiAgingCreams
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?